Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily

Clinical trial NCT01089751 · COMPLETED

Trial details

NCT number: NCT01089751
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2010-03-01
Primary completion: 2012-06-01
Enrollment: 322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.